| Similar Articles |
|---|
 |
Salon.com
December 9, 2002
Arianna Huffington |
The righteous wrath of John McCain Betrayed by the White House on campaign reform -- "They flat out broke their word," he says -- the straight-talking GOP maverick is fighting back.   |
AFP eWire
April 28, 2008 |
IRA Rollover Provision Introduced by Key Senators The chair and ranking member of the Senate Finance Committee have introduced comprehensive tax legislation that includes an extension of the IRA Rollover provision until Dec. 31, 2009. |
The Motley Fool
June 10, 2005
Stephen D. Simpson |
The High Cost of Diabetes Settling claims related to Zyprexa was probably the best of a bad set of choices for Eli Lilly. Investors need to remember to incorporate this as a risk factor for all drug companies. |
Managed Care
August 2006
John Carroll |
Congress Fails to Preserve Right of Insurers to Be Reimbursed When a plan member is treated after an auto accident or other mishap that results in an award to the member, the plan should be reimbursed, but often, it doesn't happen. |
AFP eWire
April 23, 2014 |
IRA Rollover Provision Included in Senate's EXPIRE Act The IRA Charitable Rollover has worked very successfully over the last few years, but it would be far more effective if it were made permanent. |
The Motley Fool
October 7, 2008
Brian Orelli |
Eli Lilly's Risky Gamble Eli Lilly is desperate, and the high acquisition price of ImClone shows it. |
AFP eWire
May 26, 2008 |
House Passes IRA Rollover The House of Representatives passed a bill on Wednesday, May 21, that included an extension of the IRA Rollover provision. |
The Motley Fool
December 22, 2006
Stephen Albainy-Jenei |
Is Off-Label Off-Base? Off-label prescriptions for uses lacking scientific support account for billions in drug revenue for Eli Lilly. If the FDA takes an aggressive stance on off-label-use marketing, it could significantly shrink drug sales for companies whose revenues are derived largely from such off-label use. |
National Defense
September 2010
Magnuson & Fugate |
Senators Have Low Regard for DHS Policy Reviews Republicans at a Senate Homeland Security and Governmental Affairs Committee hearing stridently criticized two DHS documents for lacking substance and stating grandiose ideals without delivering specifics. |
AFP eWire
January 28, 2008 |
AFP Urges Congress to Include IRA Rollover in Stimulus Package AFP has submitted a written statement to the Senate Finance Committee, urging Senators to include an extension of the IRA Rollover provision in the economic stimulus package currently being considered. |
AFP eWire
August 7, 2006 |
IRA Rollover Close to Final Approval The Senate passed a pension reform bill containing the IRA rollover provision and other charitable giving incentives, as well as a series of charitable reforms. |
Reason
March 2006
Veronique de Rugy |
Are We Ready for the Next 9/11? The sorry state -- and stunning waste -- of homeland security spending. |
The Motley Fool
January 5, 2004
Alyce Lomax |
Side Effects at Lilly? Growing profits, with earnings pains. |
InternetNews
March 20, 2008 |
Bush Picks Security Aide With Wiretap Background U.S. President George W. Bush named a Justice Department official with experience in terrorism wiretap programs as his White House homeland security adviser on Wednesday. |
Chemistry World
April 7, 2014
Emma Stoye |
Lilly wins cancer drug patent dispute Eli Lilly stands to gain billions of dollars in revenue from sales of chemotherapy drug Alimta in the US, after it won a legal battle to uphold a patent covering the drug's use in combination with B vitamins. |
The Motley Fool
March 27, 2008
Brian Lawler |
Eli Lilly Hands Over Cold Cash Lilly loses to the state of Alaska in a courtroom battle over its top drug Zyprexa. |
ifeminists
December 28, 2005
Tony Zizza |
If Depression Hurts, Eli Lilly Is Killing Us Eli Lilly's latest marketing campaign is a form of propaganda that speaks to how low Big Pharma will go to keep Americans in chemical handcuffs. |
Military & Aerospace Electronics
December 2006
John Keller |
Election Aftermath: What's in it for the Military? One potential target of the new Congress is the large supplemental spending budgets that fund military operations in Iraq and Afghanistan. |
The Motley Fool
June 14, 2004
Brian Gorman |
Elan Teams Up With Lilly The companies' manufacturing agreement may be more of a positive sign for Eli Lilly than it is for Elan. |
The Motley Fool
January 16, 2009
Brian Orelli |
Lilly Pays Up. Big Deal. Lawsuits are just a fact of life when investing in drug companies, and pharmaceutical investors have to expect these kinds of legal defeats. |
The Motley Fool
August 20, 2010
Brian Orelli |
Depression Is Painful. Advisory Panels More So. Eli Lilly's Cymbalta has a rough time in from of the panel of experts. |
The Motley Fool
October 2, 2008
Brian Orelli |
Will Lilly Buy ImClone's Troubles? Eli Lilly is reportedly ImClone's mystery suitor. Would it be a good deal? |
National Defense
January 2012
Stew Magnuson |
Budget Woes May Force Homeland Security To Cut Missions Sequester or no sequester, the Department of Homeland Security is in store for changes, a Senate Appropriations Committee staffer predicted. |
